---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-078774"
form_type: "8-K"
ticker: "LXEO"
cik: "0001907108"
company_name: "Lexeo Therapeutics, Inc."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:50:08.991566+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Lexeo Therapeutics stockholders elect Class I director, ratify KPMG as auditor

## Summary
- Mette Kirstine Agger elected Class I director with 14,499,254 FOR, 7,450,057 WITHHELD, 1,249,160 broker non-votes.
- Ratification of KPMG LLP as auditor for FY2024 passed: 23,194,982 FOR, 3,088 AGAINST, 401 ABSTAIN.
- Annual meeting held virtually on June 25, 2024; no other proposals were voted on.

## SEC filing metadata
- accession: 0000950170-24-078774
- form_type: 8-K
- ticker: LXEO
- cik: 0001907108
- company_name: Lexeo Therapeutics, Inc.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/0000950170-24-078774-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/lxeo-20240628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-078774
- JSON: https://secwatch.observer/filing/0000950170-24-078774.json
- Plain text: https://secwatch.observer/filing/0000950170-24-078774.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.